Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
V Tirino, V Desiderio, F Paino, A De Rosa… - The FASEB …, 2013 - Wiley Online Library
Primary tumors are responsible for 10% of cancer deaths. In most cases, the main cause of
mortality is the formation of metastases. Accumulating evidence suggests that a …
mortality is the formation of metastases. Accumulating evidence suggests that a …
[HTML][HTML] The role of human aldehyde dehydrogenase in normal and cancer stem cells
Normal stem cells and cancer stem cells (CSCs) share similar properties, in that both have
the capacity to self-renew and differentiate into multiple cell types. In both the normal stem …
the capacity to self-renew and differentiate into multiple cell types. In both the normal stem …
Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer
C Xie, X Zhou, C Liang, X Li, M Ge, Y Chen… - Journal of Experimental …, 2021 - Springer
Background Recently, a variety of clinical trials have shown that apatinib, a small-molecule
anti-angiogenic drug, exerts promising inhibitory effects on multiple solid tumors, including …
anti-angiogenic drug, exerts promising inhibitory effects on multiple solid tumors, including …
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties
ELH Leung, RR Fiscus, JW Tung, VPC Tin, LC Cheng… - PloS one, 2010 - journals.plos.org
Background The cancer stem cell theory hypothesizes that cancers are perpetuated by
cancer stem cells (CSC) or tumor initiating cells (TIC) possessing self-renewal and other …
cancer stem cells (CSC) or tumor initiating cells (TIC) possessing self-renewal and other …
Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature
Introduction Inherent and acquired cisplatin resistance reduces the effectiveness of this
agent in the management of non-small cell lung cancer (NSCLC). Understanding the …
agent in the management of non-small cell lung cancer (NSCLC). Understanding the …
Molecular biology of lung cancer: clinical implications
JE Larsen, JD Minna - Clinics in chest medicine, 2011 - chestmed.theclinics.com
Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
Stem cells and cell therapies in lung biology and lung diseases
DJ Weiss, I Bertoncello, Z Borok, C Kim… - Proceedings of the …, 2011 - atsjournals.org
EXECUTIVE SUMMARY The University of Vermont College of Medicine and the Vermont
Lung Center, with support of the National Heart, Lung, and Blood Institute (NHLBI), the …
Lung Center, with support of the National Heart, Lung, and Blood Institute (NHLBI), the …
Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives
PS Ong, LZ Wang, X Dai, SH Tseng, SJ Loo… - Frontiers in …, 2016 - frontiersin.org
The mechanistic target of rapamycin (mTOR), via its two distinct multiprotein complexes,
mTORC1, and mTORC2, plays a central role in the regulation of cellular growth, metabolism …
mTORC1, and mTORC2, plays a central role in the regulation of cellular growth, metabolism …
Survival factors regulating ovarian apoptosis--dependence on follicle differentiation
E Markstrom, EC Svensson, R Shao… - …, 2002 - rep.bioscientifica.com
Epigenetic reprogramming plays a pivotal role during embryogenesis, including both
covalent and non-covalent modifications to chromatin. In this study, we investigated the role …
covalent and non-covalent modifications to chromatin. In this study, we investigated the role …
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
R Januchowski, K Wojtowicz, M Zabel - Biomedicine & Pharmacotherapy, 2013 - Elsevier
Chemotherapy in cancer patients is still not satisfactory because of drug resistance. The
main mechanism of drug resistance results from the ability of cancer cells to actively expel …
main mechanism of drug resistance results from the ability of cancer cells to actively expel …